Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Perioperative Quantitative Sensory Testing and Incision Pain Mapping in Thoracic Surgery

NCT07653932 · Tongji Hospital · Updated 17 June 2026

What is being tested
Perioperative QST and incision pain mapping assessment
For
Postoperative Pain; Chronic Postsurgical Pain; Thoracic Surgery; Lung Resection; Mechanical Hyperalgesia; Central Sensitization
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 46 people. The full rules are on the registry page.
Where
China
When
Starts or started 8 June 2026, ends 28 Feb 2027. Registered 17 June 2026.
Results
None posted yet.

In the researchers' words

Postoperative pain remains a common and clinically important burden after thoracic surgery and may progress to chronic postsurgical pain. Conventional pain assessment mainly relies on patient-reported pain intensity and analgesic consumption, which may not fully capture peri-incisional sensory abnormalities, mechanical hyperalgesia, or central sensitization. This prospective observational pilot cohort study aims to evaluate the feasibility and acceptability of perioperative quantitative sensory testing (QST) and incision pain mapping in adult patients undergoing elective thoracoscopic or robotic-assisted lung resection. Participants will undergo baseline assessment before surgery, serial postoperative pain assessments during the first 72 hours, QST and mechanical hyperalgesia pain mapping at 48-72 hours after surgery, and follow-up assessments at discharge, 1 month, and 3 months after surgery. The primary feasibility outcomes include recruitment rate, QST completion rates, follow-up completion rates, QST-related discontinuation rate, study-related adverse events, and data completeness. The main clinical mechanistic outcome is the area of peri-incisional mechanical hyperalgesia at 48-72 hours after surgery. Secondary outcomes include acute postoperative pain intensity, pain burden over 72 hours, opioid consumption, quality of recovery, QST changes, pain-map characteristics,…
ClinicalTrials.gov, NCT07653932

Sites

  • Tongji HospitalWuhan, Hubei, China